Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05709574
What this trial is testing

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
University of Arizona 11
Testing effectiveness (Phase 2)Study completedNCT04742959
What this trial is testing

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaHER2-negative Breast Cancer+8 more
TransThera Sciences (Nanjing), Inc. 203
Testing effectiveness (Phase 2)Study completedNCT00583674
What this trial is testing

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Who this might be right for
Gastrointestinal Cancer
Amgen 171
Testing effectiveness (Phase 2)Looking for participantsNCT06468280
What this trial is testing

Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Shanghai Zhongshan Hospital 84
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Large-scale testing (Phase 3)Not Yet RecruitingNCT07603349
What this trial is testing

Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Nanfang Hospital, Southern Medical University 405
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Large-scale testing (Phase 3)UnknownNCT01786278
What this trial is testing

Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer

Who this might be right for
Adenocarcinoma of the Esophago-gastric Junction
Medical University of Lublin 80
Testing effectiveness (Phase 2)Study completedNCT06123468
What this trial is testing

Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 58
Testing effectiveness (Phase 2)Ended earlyNCT01351038
What this trial is testing

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Who this might be right for
KRAS Wild TypeResectable Type II Gastric Adenocarcinoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 43
Large-scale testing (Phase 3)Study completedNCT02314117
What this trial is testing

Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company 645
Very early researchStudy completedNCT02287168
What this trial is testing

Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients

Who this might be right for
Gastric AdenocarcinomaGastric Cancer
Bezmialem Vakif University 34
Early research (Phase 1)Not Yet RecruitingNCT06857786
What this trial is testing

Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Peking University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07050524
What this trial is testing

Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial

Who this might be right for
Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Study completedNCT00591123
What this trial is testing

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Who this might be right for
Unresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric Cardia+1 more
Translational Oncology Research International 38
Not applicableNot Yet RecruitingNCT07803159
What this trial is testing

Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Kocaeli City Hospital 328
Large-scale testing (Phase 3)Not Yet RecruitingNCT07795346
What this trial is testing

ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Antengene Biologics Limited 380
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT00938470
What this trial is testing

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 73
Testing effectiveness (Phase 2)Study completedNCT01362127
What this trial is testing

Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia

Who this might be right for
Carcinoma, Squamous CellAdenocarcinoma of the Esophagus and Gastric Cardia
Karolinska University Hospital 181
Next Page